Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric Adenocarcinoma

1 clinical trials · Condition

Record	Firm	Date
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. (NCT06349044)	Zhejiang Cancer Hospital	2024-03-20

Every clearance here is in the API, with alerts when new ones post.